KYTX vs WAB · $488.8M cap vs P/E 38, rev $3.18B
Kyverna Therapeutics, Inc. Common Stock (KYTX) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
KYTX does not have a complete income-statement cache yet.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
KYTX currently screens at market cap $488.8M. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the KYTX and WAB stock pages for the full models.
Not investment advice.